Compass Therapeutics (CMPX) Payables (2023 - 2025)
Historic Payables for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $3.1 million.
- Compass Therapeutics' Payables rose 22239.58% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 22239.58%. This contributed to the annual value of $2.2 million for FY2024, which is 4501.22% down from last year.
- According to the latest figures from Q3 2025, Compass Therapeutics' Payables is $3.1 million, which was up 22239.58% from $2.6 million recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Payables ranged from a high of $4.1 million in Q4 2023 and a low of $724000.0 during Q2 2023
- In the last 3 years, Compass Therapeutics' Payables had a median value of $1.6 million in 2025 and averaged $1.9 million.
- As far as peak fluctuations go, Compass Therapeutics' Payables crashed by 5836.95% in 2024, and later surged by 22239.58% in 2025.
- Compass Therapeutics' Payables (Quarter) stood at $4.1 million in 2023, then crashed by 45.01% to $2.2 million in 2024, then skyrocketed by 37.62% to $3.1 million in 2025.
- Its last three reported values are $3.1 million in Q3 2025, $2.6 million for Q2 2025, and $1.6 million during Q1 2025.